Analyst
UBS
Equibles does not estimate personal net worth.
Nusrat Hussain is recorded as Analyst at UBS. Nusrat Hussain has spoken on 1 earnings call across 1 company, most recently for IPSEN on July 30, 2026. The companies whose calls Nusrat Hussain spoke on are classified in the Healthcare sector.
“Firstly, on the guidance upgrade, could you quantify how much of this reflects the delayed somatulin generic entry versus the rest of the portfolio? And secondly, how do you expect the recent Dara data to affect Onivite?”
UBS
Analyst
Transcript header (unverified)
IPSEN
Drug Manufacturers - Specialty & Generic · Healthcare
Ipsen H1 2026 Results Call
IPSEN
